Skip to main content
Premium Trial:

Request an Annual Quote

Rescentris Secures Series A Funding

NEW YORK, May 4 (GenomeWeb News) - Rescentris, a provider of electronic laboratory notebook software, said today that it has completed its Series A financing.


The company did not disclose the amount of funding, but said that it will be used to expand its sales and marketing programs and further development of its flagship product, the Collaborative Electronic Research Framework (CERF).


Initial development of CERF was funded in part by a grant from the State of Ohio's Third Frontier Project, Rescentris said.


The product was developed in collaboration with OhioStateUniversity's BioMedical Informatics department.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.